Forecast & Rating2 analysts currently cover Greenwich Lifesciences, of which 2 give a positive rating. The average price target is $57.00, about 283.6% upside from the current price of $14.86. Coverage is limited, so the data is for reference only. Data as of Jul 21, 2026; this does not constitute investment advice.
Jul 21, 2026Price forecast
$57.00283.58%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 7, 2026
Forecast met0.0%
Stock price$14.86
Avg. target$57.0
High target$69
Low target$45
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.